Arcturus Therapeutics Holdings (ARCT) has an average rating of buy and mean price target of $23.20, according to analysts polled by FactSet.
What else is happening in Research?
Research
Deutsche Bank Cuts TUI Group PT, Maintains Buy Rating
Deutsche Bank on Tuesday decreased the price target for German tourism company TUI Group (TUI1.F) to 10.1 euros from 10.5 euros, while affirming its buy rating.
$TUI1.F
Research
Mwb Trims KWS PT, Keeps Buy Rating
Mwb on Wednesday reduced its price target for German plant breeding company KWS (KWS.F) to 93 euros from 95 euros, with an unchanged buy rating.
$KWS.F
Research
Oppenheimer Upgrades Innoviva to Outperform From Neutral, $35 Price Target
$INVA